cardiovascular disease

Calculating the polygenic risk scores of ancient humans such as Ötzi the iceman helps researchers understand the genetic predisposition to cardiovascular disease.

In this webinar event, Vivienne Watson from Amgen will answer questions that delve deeper into the entire podcast series.

Hector Cabrera Fuentes, a renowned cardiovascular researcher, collaborated with Russian intelligence agents for more than a year, prosecutors said.

Explore how technology enables large-scale proteomics for biomarker discovery and clinical application.

He was among the first to identify lifestyle factors that contribute to cardiovascular disease.

The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.

Experts have a decent grasp on how COVID-19 impacts cardiovascular health in the near term. The implications of long COVID, however, remain mysterious.

The procedure, performed last Friday, is a milestone in a long effort to boost the number of organs available for safe transplantation.

The Scientist spoke with Rachel Zeig-Owens, the director of epidemiology for the World Trade Center Health Program, about what scientists have learned after two decades of studying illness and disease among survivors.

Using deoxyoligonucleotides to bind proteins with high sensitivity and specificity

Research in mice and humans points to oxidative stress and inflammation as likely drivers of noise-induced health effects such as hypertension and heart disease.

Meet some of the people featured in the June 2021 issue of The Scientist.

Sound from cars, aircraft, trains, and other man-made machines is more than just annoying. It increases the risk of cardiovascular disease.

The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.

Single Molecule Counting (SMC™) technology offers the sensitivity to reveal hidden biomarker information

John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.